Prospective Evaluation Of Outcomes For Patients Undergoing Radiofrequency Ablation (RFA) Using HALO Ultra Device For Gastric Antral Vascular Ectasia (GAVE)

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational [Patient Registry]
SUMMARY

The purpose: To determine the safety and efficacy of Radiofrequency Ablation (RFA) HALO Ultra system in patients with Gastric Antral Vascular Ectasia patient cohort (GAVE). Research design: This is a prospective observational study. Procedure Used: Radiofrequency Ablation Risks and potential benefits: There are no risks associated with this study as it is a retrospective chart review. Potential benefits include the knowledge gained from this study which may be of help to patients in the future. Importance of knowledge that may reasonably be expected to result The knowledge gained from this study may be of help to other patients in the future.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: No
View:

• In-patients

• Patients diagnosed with GAVE

• Patients undergoing radiofrequency ablation with HALO ULTRA device

Locations
United States
Texas
Memorial Hermann Hospital
Recruiting
Houston
Contact Information
Primary
Prithvi B Patil, MS
prithvi.b.patil@uth.tmc.edu
713-500-6654
Backup
Nirav Thosani, MD
nirav.thosani@uth.tmc.edu
7135006457
Time Frame
Start Date: August 2015
Estimated Completion Date: December 2025
Participants
Target number of participants: 1000
Sponsors
Leads: The University of Texas Health Science Center, Houston

This content was sourced from clinicaltrials.gov

Similar Clinical Trials